Upeka De Silva

Upeka De Silva

Auto-generated profile, based on publicly available information

Upeka De Silva

Department of Data Science and Artificial Intelligence, AUT, New Zealand

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
USUpeka De Silva
Upeka De Silva
Samaneh MadanianSamaneh Madanian
Samaneh Madanian
Sharon OlsenSharon Olsen
Sharon Olsen
John TempletonJohn Templeton
John Templeton
CPChristian Poellabauer
Christian Poellabauer
RRRahmina Rubaiat
Rahmina Rubaiat
Background: Digital biomarkers are increasingly used in clinical decision support for various health conditions. Speech features as digital biomarkers can offer insights into underlying physiological processes due to the complexity of speech production. This process involves respiration, phonation, articulation, and resonance, all of which rely on specific motor systems for the preparation and execution of speech. Deficits in any of these systems can cause changes in speech signal patterns. Increasing efforts are being made to develop speech-based clinical decision support systems. Objective: This systematic scoping review investigated the technological revolution and recent digital clinical speech signal analysis trends to understand the key concepts and research processes from clinical and technical perspectives. Methods: A systematic scoping review was undertaken in 6 databases guided by a set of research questions. Articles that focused on speech signal analysis for clinical decision-making were identified, and the included studies were analyzed quantitatively. A narrower scope of studies investigating neurological diseases were analyzed using qualitative content analysis. Results: A total of 389 articles met the initial eligibility criteria, of which 72 (18.5%) that focused on neurological diseases were included in the qualitative analysis. In the included studies, Parkinson disease, Alzheimer disease, and cognitive disorders were the most frequently investigated conditions. The literature explored the potential of speech feature analysis in diagnosis, differentiating between, assessing the severity and monitoring the treatment of neurological conditions. The common speech tasks used were sustained phonations, diadochokinetic tasks, reading tasks, activity-based tasks, picture descriptions, and prompted speech tasks. From these tasks, conventional speech features (such as fundamental frequency, jitter, and shimmer), advanced digital signal processing–based speech features (such as wavelet transformation–based features), and spectrograms in the form of audio images were analyzed. Traditional machine learning and deep learning approaches were used to build predictive models, whereas statistical analysis assessed variable relationships and reliability of speech features. Model evaluations primarily focused on analytical validations. A significant research gap was identified: the need for a structured research process to guide studies toward potential technological intervention in clinical settings. To address this, a research framework was proposed that adapts a design science research methodology to guide research studies systematically. Conclusions: The findings highlight how data science techniques can enhance speech signal analysis to support clinical decision-making. By combining knowledge from clinical practice, speech science, and data science within a structured research framework, future research may achieve greater clinical relevance.

12 February 2025 in JMIR Neurotechnology
Verified
Journal Article
Open access
RRRahmina Rubaiat
Rahmina Rubaiat
John TempletonJohn Templeton
John Templeton
SSSandra L Schneider
Sandra L Schneider
USUpeka De Silva
Upeka De Silva
Samaneh MadanianSamaneh Madanian
Samaneh Madanian
CPChristian Poellabauer
Christian Poellabauer
Background: Speech features are increasingly linked to neurodegenerative and mental health conditions, offering the potential for early detection and differentiation between disorders. As interest in speech analysis grows, distinguishing between conditions becomes critical for reliable diagnosis and assessment. Objective: This pilot study explores speech biosignatures in two distinct neurodegenerative conditions: (1) mild traumatic brain injuries (eg, concussions) and (2) Parkinson disease (PD) as the neurodegenerative condition. Methods: The study included speech samples from 235 participants (97 concussed and 94 age-matched healthy controls, 29 PD and 15 healthy controls) for the PaTaKa test and 239 participants (91 concussed and 104 healthy controls, 29 PD and 15 healthy controls) for the Sustained Vowel (/ah/) test. Age-matched healthy controls were used. Young age-matched controls were used for concussion and respective age-matched controls for neurodegenerative participants (15 healthy samples for both tests). Data augmentation with noise was applied to balance small datasets for neurodegenerative and healthy controls. Machine learning models (support vector machine, decision tree, random forest, and Extreme Gradient Boosting) were employed using 37 temporal and spectral speech features. A 5-fold stratified cross-validation was used to evaluate classification performance. Results: For the PaTaKa test, classifiers performed well, achieving F1-scores above 0.9 for concussed versus healthy and concussed versus neurodegenerative classifications across all models. Initial tests using the original dataset for neurodegenerative versus healthy classification yielded very poor results, with F1-scores below 0.2 and accuracy under 30% (eg, below 12 out of 44 correctly classified samples) across all models. This underscored the need for data augmentation, which significantly improved performance to 60%‐70% (eg, 26‐31 out of 44 samples) accuracy. In contrast, the Sustained Vowel test showed mixed results; F1-scores remained high (more than 0.85 across all models) for concussed versus neurodegenerative classifications but were significantly lower for concussed versus healthy (0.59‐0.62) and neurodegenerative versus healthy (0.33‐0.77), depending on the model. Conclusions: This study highlights the potential of speech features as biomarkers for neurodegenerative conditions. The PaTaKa test exhibited strong discriminative ability, especially for concussed versus neurodegenerative and concussed versus healthy tasks, whereas challenges remain for neurodegenerative versus healthy classification. These findings emphasize the need for further exploration of speech-based tools for differential diagnosis and early identification in neurodegenerative health.

25 January 2024
Verified
Book Chapter
Open access
PDF file
USUpeka De Silva
Upeka De Silva
Samaneh MadanianSamaneh Madanian
Samaneh Madanian
JTJohn Michael Templeton
John Michael Templeton
CPChristian Poellabauer
Christian Poellabauer
SSSandra L. Schneider
Sandra L. Schneider
DPDave Parry
Dave Parry
Mental health (MH) has become a global issue. Digital phenotyping in mental healthcare provides a highly effective, scaled, cost-effective approach to handling global MH problems. We propose an MH monitoring application. The application monitors overall MH based on mood, stress, behavior, and personality. Further, it proposes objective MH assessment from smartphone data and subjective screening of MH via periodic, short, self-report standardized questionnaires.

7 August 2025
Verified
Book Chapter
Open access
USUpeka De Silva
Upeka De Silva
SMSamaneh Madanian
Samaneh Madanian
ANAjit Narayanan
Ajit Narayanan
JTJohn Michael Templeton
John Michael Templeton
CPChristian Poellabauer
Christian Poellabauer
RRRahmina Rubaiat
Rahmina Rubaiat
Speech signal analysis to support objective clinical decision-making has gained immense interest, especially in neurological disorders. This research assessed the feasibility of speech analysis on the detection of concussions. Using a speech dataset from 82 concussed and 82 healthy participants, we extracted two speech feature sets focusing on Mel Frequency Cepstral Coefficients (MFCCs) to characterize speech articulation. A machine learning pipeline was developed to discriminate concussion speech from healthy speech by applying Support Vector Machine (SVM), K-Nearest Neighbors (KNN), and Decision Tree (DT) classifiers. All three classifiers trained on the MFCC-based feature set achieved Matthew’s correlation coefficient score above 0.5 on the holdout data set. DT model achieved a 78% sensitivity and 75% specificity. The findings of this research serve as proof-of-concept for speech analysis of concussion detection.

9 June 2024 in JMIR Preprints
Verified
Preprint
Open access
USUpeka De Silva
Upeka De Silva
Samaneh MadanianSamaneh Madanian
Samaneh Madanian
Sharon OlsenSharon Olsen
Sharon Olsen
John TempletonJohn Templeton
John Templeton
CPChristian Poellabauer
Christian Poellabauer
RRRahmina Rubaiat
Rahmina Rubaiat
BACKGROUND Digital biomarkers are increasingly used in clinical decision support for various health conditions. Speech features as digital biomarkers can offer insights into underlying physiological processes due to the complexity of speech production. This process involves respiration, phonation, articulation, and resonance, all of which rely on specific motor systems for the preparation and execution of speech. Deficits in any of these systems can cause changes in speech signal patterns. Increasing efforts are being made to develop speech-based clinical decision support systems. OBJECTIVE This systematic scoping review investigated the technological revolution and recent digital clinical speech signal analysis trends to understand the key concepts and research processes from clinical and technical perspectives. METHODS A systematic scoping review was undertaken in 6 databases guided by a set of research questions. Articles that focused on speech signal analysis for clinical decision-making were identified, and the included studies were analyzed quantitatively. A narrower scope of studies investigating neurological diseases were analyzed using qualitative content analysis. RESULTS A total of 389 articles met the initial eligibility criteria, of which 72 (18.5%) that focused on neurological diseases were included in the qualitative analysis. In the included studies, Parkinson disease, Alzheimer disease, and cognitive disorders were the most frequently investigated conditions. The literature explored the potential of speech feature analysis in diagnosis, differentiating between, assessing the severity and monitoring the treatment of neurological conditions. The common speech tasks used were sustained phonations, diadochokinetic tasks, reading tasks, activity-based tasks, picture descriptions, and prompted speech tasks. From these tasks, conventional speech features (such as fundamental frequency, jitter, and shimmer), advanced digital signal processing–based speech features (such as wavelet transformation–based features), and spectrograms in the form of audio images were analyzed. Traditional machine learning and deep learning approaches were used to build predictive models, whereas statistical analysis assessed variable relationships and reliability of speech features. Model evaluations primarily focused on analytical validations. A significant research gap was identified: the need for a structured research process to guide studies toward potential technological intervention in clinical settings. To address this, a research framework was proposed that adapts a design science research methodology to guide research studies systematically. CONCLUSIONS The findings highlight how data science techniques can enhance speech signal analysis to support clinical decision-making. By combining knowledge from clinical practice, speech science, and data science within a structured research framework, future research may achieve greater clinical relevance.

22 July 2024 in JMIR Preprints
Verified
Preprint
Open access
RRRahmina Rubaiat
Rahmina Rubaiat
JTJohn Michael Templeton
John Michael Templeton
SSSandra L. Schneider
Sandra L. Schneider
USUpeka De Silva
Upeka De Silva
Samaneh MadanianSamaneh Madanian
Samaneh Madanian
CPChristian Poellabauer
Christian Poellabauer
BACKGROUND Changes in various speech features have been linked to various neurological and mental health-related pathologies; these changes can often be detected years before a definitive clinical diagnosis. With the growing interest in using speech analysis for detecting a myriad of health conditions and the growing number of patients with multiple health problems, it will be increasingly important to demonstrate that speech analysis can differentiate between these conditions, to provide reliable and accurate diagnosis and assessment. OBJECTIVE Toward this end, this study takes a first step in this direction by examining the speech biosignatures of two common neurological conditions: (1) mild traumatic brain injuries (such as concussions) and (2) neurodegenerative diseases, particularly focusing on amyotrophic lateral sclerosis (ALS) and Parkinson's Disease (PD). METHODS Further, this study utilizes two specific types of speech tests well-known to and frequently used by speech-language pathologists: a diadochokinetic test (“PaTaKa test”) and a sustained vowel test. This work investigates data from over 230 participants and examines 25 temporal and 12 spectral features of sound. We trained classification models using four popular machine learning algorithms including Support Vector Machine, Decision Tree, Random Forest, and Extreme Gradient Boosting (XGBoost) with three speech feature sets selected considering statistical significance based on the analysis of variance (ANOVA). RESULTS The results show that out of these 37 features, over 20 show statistical significance in differentiating between concussions, neurodegenerative diseases, and healthy controls. The paper further compares the performance of different classification models using these features. For the PaTaKa test, when the entire speech feature set was used, Decision Tree obtained the highest F1 score of 0.98 among the four classifiers. When the most significant speech feature set that has ANOVA p-values less than 0.05 was used, the highest F1-score (0.95) was obtained using XGBoost. A maximum F1-score of 0.93 was obtained with both Random Forest and XGBoost when the top statistically significant 5 features were used in model training. None of the classifiers could achieve an F1-score over 0.7 with speech features obtained through sustained vowel test. CONCLUSIONS This study demonstrated that the speech signatures of individuals with concussions, individuals with neurodegenerative conditions, and healthy controls differ in a way that allows us to identify unique patterns in speech associated with each condition, providing opportunities for the development of speech-based biomarkers for early detection and more accurate diagnosis. The findings of this study also indicate that it is feasible to use speech analysis to detect multiple different health conditions within the same person.